In a cross-sectional study, lipid accumulation product, which, just like afamin is a powerful marker of MS in the general population was also reported elevated in AGHD, and proved to have a strong diagnostic accuracy for MS in GH-deficient adults (53). Here, GH1 is linked to myeloid sarcoma.